This single-center retrospective study determines the long-term hepatotoxicity of Yttrium-90 Radioembolization (Y90) in patients treated for metastatic neuroendocrine tumor (mNET), and evaluates if imaging and laboratory findings of cirrhosis-like morphology has limited clinical symptoms. This program is designed to meet the educational needs of interventional radiologists, hepatologists, oncologists, radiation-oncologists, hepato-biliary surgeons, nurses, techs, and trainees at all level with special interest in HCC.
The SIR Journal CME Program is a convenient way to fulfill your CME requirements while learning about the latest advances in medicine and research. Each month, one article in the Journal of Vascular and Interventional Radiology (JVIR) will have a companion CME exam. To receive CME credit for this journal-based CME activity, participants must read the journal article and score 70% or better on the exam. Participants will have three opportunities to score 70% or better.
After purchasing access to this educational activity, you will be directed to the SIR Learning Center to participate in the activity and obtain your certificate.
After participating in this journal-based CME activity, learners should be able to
Cite the median time to development of cirrhosis-like morphology (on imaging) after Y90.
List the differences in developing long-term imaging findings of cirrhosis and portal hypertension in patients treated with whole-liver and unilobar Y90 administration.
Identify patients at risk of developing long-term hepatotoxicity from Y90 administration.
JVIR CME Editor
Nishita Kothary, MD
Stanford University Medical Center, Stanford CA
Yu-Kai Su, MD
Rosewell V. Mackey, MD
Ahsun Riaz, MD
Vanessa L. Gates, MS
Al B. Benson III, MD
Frank H. Miller, MD
Vahid Yaghmai, MD
Ahmed Gabr, MD
Riad Salem, MD
Robert J. Lewandowski, MD
Northwestern University, Feinberg School of Medicine, Department of Radiology
This activity has been planned and implemented in accordance with the Essentials and Standards of the Accreditation Council for Continuing Medical Education (ACCME).
The Society of Interventional Radiology (SIR) is accredited by the ACCME to provide continuing medical education for physicians. SIR designates this education activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This program is approved for 1 self-assessment CME credit (SA-CME) by the Society of Interventional Radiology (SIR) - approved October 1, 2017. SIR is awarded Deemed Status by the American Board of Radiology (ABR). The SA-CME credit offered for this enduring activity meets the ABR’s criteria for self-assessment toward the purpose of fulfilling requirements in the ABR Maintenance of Certification (MOC) Program.